Literature DB >> 8978697

Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo.

D Krappmann1, F G Wulczyn, C Scheidereit.   

Abstract

The transcription factor NF-kappaB is sequestered in the cytoplasm by a family of IkappaB molecules. Upon cellular stimulation with diverse agents, one of these molecules, IkappaB alpha, is rapidly phosphorylated and subsequently degraded. This process triggers nuclear translocation of NF-kappaB and the successive activation of target genes. Independent of its rapid stimulation-induced breakdown, IkappaB alpha is inherently unstable and undergoes a continuous turnover. To compare the mechanisms and protein domains involved in inducible and basal degradation of IkappaB alpha in intact cells we employed a transfection strategy using tagged IkappaB alpha and ubiquitin molecules. We show that tumor necrosis factor alpha (TNFalpha) induced breakdown of IkappaB alpha but not its basal turnover coincides with ubiquitination in the amino-terminal signal response domain (SRD) of IkappaB alpha. Neither the SRD nor the carboxy-terminal PEST sequence is needed for basal turnover, which instead depends only on the core ankyrin repeat domain. Despite the differences in the requirements of protein domains and ubiquitin-conjugation for both degradation pathways, each one is mediated by the proteasome. This finding is important for understanding alternative modes of controlling NF-kappaB activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8978697      PMCID: PMC452495     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  62 in total

1.  Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation.

Authors:  J DiDonato; F Mercurio; C Rosette; J Wu-Li; H Suyang; S Ghosh; M Karin
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

2.  Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism.

Authors:  R Sen; D Baltimore
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

3.  Constitutive phosphorylation of I kappa B alpha by casein kinase II.

Authors:  C F Barroga; J K Stevenson; E M Schwarz; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

4.  Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis.

Authors:  S Rogers; R Wells; M Rechsteiner
Journal:  Science       Date:  1986-10-17       Impact factor: 47.728

5.  In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B.

Authors:  I Alkalay; A Yaron; A Hatzubai; S Jung; A Avraham; O Gerlitz; I Pashut-Lavon; Y Ben-Neriah
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

6.  Constitutive phosphorylation of IkappaBalpha by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IkappaBalpha.

Authors:  E M Schwarz; D Van Antwerp; I M Verma
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

7.  The ankyrin repeats but not the PEST-like sequences are required for signal-dependent degradation of IkappaBalpha.

Authors:  T Aoki; Y Sano; T Yamamoto; J I Inoue
Journal:  Oncogene       Date:  1996-03-07       Impact factor: 9.867

8.  Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity.

Authors:  J Inoue; L D Kerr; D Rashid; N Davis; H R Bose; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

9.  Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity.

Authors:  S Haskill; A A Beg; S M Tompkins; J S Morris; A D Yurochko; A Sampson-Johannes; K Mondal; P Ralph; A S Baldwin
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

10.  The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B.

Authors:  M Naumann; F G Wulczyn; C Scheidereit
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

View more
  65 in total

Review 1.  Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo?

Authors:  C Salvat; C Aquaviva; I Jariel-Encontre; P Ferrara; M Pariat; A M Steff; S Carillo; M Piechaczyk
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

2.  Human T-cell leukemia virus type 1 Tax protein binds to assembled nuclear proteasomes and enhances their proteolytic activity.

Authors:  J Hemelaar; F Bex; B Booth; V Cerundolo; A McMichael; S Daenke
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

3.  Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein.

Authors:  Robert F Kalejta; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

4.  The COOH-terminal domain of wild-type Cot regulates its stability and kinase specific activity.

Authors:  Maria Luisa Gándara; Pilar López; Raquel Hernando; José G Castaño; Susana Alemany
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

5.  Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells.

Authors:  Shelby O'Connor; Stuart D Shumway; Ian J Amanna; Colleen E Hayes; Shigeki Miyamoto
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

6.  Validation of IKK beta as therapeutic target in airway inflammatory disease by adenoviral-mediated delivery of dominant-negative IKK beta to pulmonary epithelial cells.

Authors:  Matthew C Catley; Joanna E Chivers; Neil S Holden; Peter J Barnes; Robert Newton
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

7.  Adipocyte enhancer-binding protein-1 promotes macrophage inflammatory responsiveness by up-regulating NF-kappaB via IkappaBalpha negative regulation.

Authors:  Amin Majdalawieh; Lei Zhang; Hyo-Sung Ro
Journal:  Mol Biol Cell       Date:  2007-01-03       Impact factor: 4.138

8.  Potentiation of NF-kappaB-dependent transcription and inflammatory mediator release by histamine in human airway epithelial cells.

Authors:  N S Holden; W Gong; E M King; M Kaur; M A Giembycz; R Newton
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

9.  c-Fos proto-oncoprotein is degraded by the proteasome independently of its own ubiquitinylation in vivo.

Authors:  Guillaume Bossis; Patrizia Ferrara; Claire Acquaviva; Isabelle Jariel-Encontre; Marc Piechaczyk
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  Sequential DNA damage-independent and -dependent activation of NF-kappaB by UV.

Authors:  K Bender; M Göttlicher; S Whiteside; H J Rahmsdorf; P Herrlich
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.